
Opinion|Videos|October 16, 2026
Discussion Surrounding the Definition of Cure in Multiple Myeloma
The faculty consider how they would answer a patient who is 5 years out from a single infusion in sustained MRD-negative remission and asks whether they are cured.
Advertisement
Episodes in this series

The faculty consider how they would answer a patient who is 5 years out from a single infusion in sustained MRD-negative remission and asks whether they are cured. They refer to the provisional International Myeloma Society and International Myeloma Working Group definition of cure and describe how they use the words cure and long-term remission with patients. The panel also discusses the appeal of time off therapy, including quality of life, financial and time, and how the cost of CAR-T compares with continuous therapy.
Advertisement
Related to this article

Erik Bengtsen, MD, explained how antidepressants may improve quality of life and how he typically works with patients who decline favorable treatment.

Erik Bengtsen, MD, shares a key depression screening question and explains when oncologists can start a low-dose antidepressant.
Advertisement
Advertisement
Trending on CancerNetwork
1
VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors
2
Personalized Cancer Vaccine Combo Is Feasible in Platinum-Sensitive Ovarian Cancer
3
Proton Therapy Tied to Less Hypothyroidism After Supraclavicular Breast RT
4
ASH Issues New Myelofibrosis Guidelines With 10 Management Recommendations
5

